Non- Small Cell Lung Cancer-NSCLC
Non-Small Cell Lung Cancer (NSCLC) is the most common type of lung cancer, characterized by slow progression but complex treatment needs.
CureU Healthcare offers state-of-the-art diagnosis and targeted treatments to improve survival and quality of life.
Overview And Clinical Background
Non-Small Cell Lung Cancer comprises multiple subtypes such as adenocarcinoma, squamous cell carcinoma, and large cell carcinoma.
It’s linked with smoking, pollution, and genetic predisposition.
Symptoms, Signs And Presentation
Patients may show cough, chest pain, or shortness of breath.
Weight loss and fatigue often indicate disease spread.
Diagnosis Methods And Investigations
Diagnosis includes imaging, biopsy, and molecular testing for mutations.
Staging determines the extent of disease and guides treatment.
Treatment Options And Surgical Techniques
Treatment is tailored to cancer stage, type, and patient condition.
It includes surgery, chemotherapy, radiotherapy, and targeted therapy.
Recovery, Risks And Prognosis
Recovery depends on disease stage and treatment modality.
Early detection improves outcomes; advanced cases may need long-term care.
Why Choose Us
CureU Healthcare combines advanced oncology expertise, multidisciplinary collaboration, and personalized care for each NSCLC patient.
Focus on comfort, compassion, and cutting-edge results.
Conclusion
With timely intervention and precision medicine, NSCLC can be managed effectively.
CureU Healthcare ensures every patient receives individualized, evidence-based care.
